EP0409893A4 - Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration - Google Patents

Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration

Info

Publication number
EP0409893A4
EP0409893A4 EP19890904967 EP89904967A EP0409893A4 EP 0409893 A4 EP0409893 A4 EP 0409893A4 EP 19890904967 EP19890904967 EP 19890904967 EP 89904967 A EP89904967 A EP 89904967A EP 0409893 A4 EP0409893 A4 EP 0409893A4
Authority
EP
European Patent Office
Prior art keywords
methods
administration
preparation
pharmaceutical formulations
magnetically influenced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19890904967
Other languages
English (en)
Other versions
EP0409893A1 (en
Inventor
Walter Whitson Fischman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0409893A1 publication Critical patent/EP0409893A1/en
Publication of EP0409893A4 publication Critical patent/EP0409893A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
EP19890904967 1988-04-01 1989-04-03 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration Withdrawn EP0409893A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17673188A 1988-04-01 1988-04-01
US176731 1988-04-01

Publications (2)

Publication Number Publication Date
EP0409893A1 EP0409893A1 (en) 1991-01-30
EP0409893A4 true EP0409893A4 (en) 1991-03-13

Family

ID=22645606

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890904967 Withdrawn EP0409893A4 (en) 1988-04-01 1989-04-03 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration

Country Status (7)

Country Link
EP (1) EP0409893A4 (ja)
JP (1) JPH03503648A (ja)
AU (1) AU632481B2 (ja)
CA (1) CA1334936C (ja)
IN (1) IN169075B (ja)
NZ (1) NZ228593A (ja)
WO (1) WO1989009049A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243476B (it) * 1990-08-01 1994-06-15 Enza Ciccolo Metodo per il riconoscimento di attivita' frequenziali e bioenergetiche in acque e loro uso
FR2675385B1 (fr) * 1991-04-18 1993-07-23 Boulay Maurice Produit calmant et revitalisant contenant de la poudre d'aimant.
WO1993003712A1 (en) * 1991-08-20 1993-03-04 Daniel Mcnair A device for the administration of homeopathic compositions
IT1290779B1 (it) * 1995-06-26 1998-12-10 Antonio Sacchetti Procedimento per il potenziamento delle attivita' terapeutiche di sostanze naturali (vitamine, minerali, erbe, fitopreparati, alimenti)
WO2002066041A1 (en) * 2001-02-23 2002-08-29 Herbal Detox Therapy Aps Natural composition
US6552035B2 (en) * 2001-09-13 2003-04-22 Hwa-Mok Park Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhae
US6844014B1 (en) 2002-07-22 2005-01-18 Stephen Rafkin Herbal healing lotion for veterinary use
DE202014103194U1 (de) * 2014-07-11 2014-07-29 Marianna Gross Homöopathisches Mittel zur Raucherentwöhnung

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671451A (en) * 1952-06-16 1954-03-09 Stephen J Bolger Remedial pill
DE1467974A1 (de) * 1964-06-08 1969-01-23 Tsukamoto Kenkichi Verfahren zur Verbesserung der Wirksamkeit von Eisenpraeparaten und Vorrichtung zur Durchfuehrung des Verfahrens
DE1492136A1 (de) * 1965-01-30 1969-09-18 Seuss Dr Med Willy Einrichtung zur therapeutischen Beeinflussung des menschlichen Koerpers durch statische Elektrizitaet
DE2062080A1 (de) * 1969-12-23 1971-07-01 Sohman, Henri, Toulouse, Haute Ga rönne (Frankreich) Mineral vegetables Medikament, ins besondere zur Behandlung der Struma
GB1264511A (ja) * 1968-02-24 1972-02-23
FR2258839A1 (en) * 1974-01-28 1975-08-22 Sitbon Georges Colloidal therapeutic iron solutions - treatment for cancer, leukaemia, arterial and cardiac disorders, neurological disorders, anti-radiation agents, etc.
EP0000667A1 (en) * 1977-08-01 1979-02-07 Northwestern University Intravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation
EP0035932A1 (fr) * 1980-03-03 1981-09-16 FLUX YANG Societé Civile Dispositif pour l'application d'un champ magnétique
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
DE3634121A1 (de) * 1986-05-09 1987-11-12 Otto Kausch Verfahren und einrichtung zur verbesserung der wirkungen fluessiger oder pastoeser praeparate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE431214B (sv) * 1977-06-02 1984-01-23 Klaus H Mosbach Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans
JPS576041A (en) * 1980-02-25 1982-01-12 Kimikiyo Harada Folding formation type metal stud
US4501726A (en) * 1981-11-12 1985-02-26 Schroeder Ulf Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
JPS5945378A (ja) * 1982-09-09 1984-03-14 Toyobo Co Ltd 粘着材料
JPS6032716A (ja) * 1983-07-29 1985-02-19 Yasuo Sawada 特殊脂肪酸と磁化鉄粉含有の殺菌薬と病体の恢復力を速める薬の製造方法
JPS61115015A (ja) * 1984-11-08 1986-06-02 Shimazaki Shiyubiyou Kk 帯磁化粧品
JPS62175419A (ja) * 1986-01-25 1987-08-01 Tomoji Tanaka 人工温泉浴剤
JPS63159313A (ja) * 1986-12-24 1988-07-02 Olympus Optical Co Ltd 治療用薬剤

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671451A (en) * 1952-06-16 1954-03-09 Stephen J Bolger Remedial pill
DE1467974A1 (de) * 1964-06-08 1969-01-23 Tsukamoto Kenkichi Verfahren zur Verbesserung der Wirksamkeit von Eisenpraeparaten und Vorrichtung zur Durchfuehrung des Verfahrens
DE1492136A1 (de) * 1965-01-30 1969-09-18 Seuss Dr Med Willy Einrichtung zur therapeutischen Beeinflussung des menschlichen Koerpers durch statische Elektrizitaet
GB1264511A (ja) * 1968-02-24 1972-02-23
DE2062080A1 (de) * 1969-12-23 1971-07-01 Sohman, Henri, Toulouse, Haute Ga rönne (Frankreich) Mineral vegetables Medikament, ins besondere zur Behandlung der Struma
FR2258839A1 (en) * 1974-01-28 1975-08-22 Sitbon Georges Colloidal therapeutic iron solutions - treatment for cancer, leukaemia, arterial and cardiac disorders, neurological disorders, anti-radiation agents, etc.
EP0000667A1 (en) * 1977-08-01 1979-02-07 Northwestern University Intravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation
EP0035932A1 (fr) * 1980-03-03 1981-09-16 FLUX YANG Societé Civile Dispositif pour l'application d'un champ magnétique
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
DE3634121A1 (de) * 1986-05-09 1987-11-12 Otto Kausch Verfahren und einrichtung zur verbesserung der wirkungen fluessiger oder pastoeser praeparate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DERWENT FILE SUPPLIER WPIL, 1985, accession no. 85-078983 [13], Derwent Publications Ltd, London, GB; & JP-A-60 032 716 (SAWADA) 19-02-1985 *
PATENT ABSTRACTS OF JAPAN, vol. 10, no. 303 (C-378)[2359], 16th October 1986; & JP-A-61 115 015 (SHIMAZAKI SHIYUBIYOU K.K.) 02-06-1986 *
See also references of WO8909049A1 *

Also Published As

Publication number Publication date
CA1334936C (en) 1995-03-28
AU632481B2 (en) 1993-01-07
NZ228593A (en) 1992-07-28
IN169075B (ja) 1991-08-31
EP0409893A1 (en) 1991-01-30
AU3426089A (en) 1989-10-16
WO1989009049A1 (en) 1989-10-05
JPH03503648A (ja) 1991-08-15

Similar Documents

Publication Publication Date Title
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
IL91069A (en) Intravenous pharmaceutical compositions and their preparation
GR860342B (en) 11b- phenyl-gonane their preparation and pharmaceutical preparations containing them
HK1003114A1 (en) FLuorocytidine derivatives their preparation and medical preparations containing them
IL88182A0 (en) Derivatives of 1-desoxynojirimicyin and 1-desoxymannonojirimycin,their preparation and their use in medicaments
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
HRP920229A2 (en) Release of medicinal substances and preparation process therefor
IL78219A0 (en) N,n'-dialkylguanidino dipeptide derivatives,their preparation and pharmaceutical compositions containing them
IL84946A0 (en) Drug delivery compositions and their preparation
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
NZ219015A (en) Thieno-1,4-diazepine derivatives and pharmaceutical compositions:intermediates in their preparation
PH25104A (en) Acyl derivatives and pharmaceutical preparation thereof
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
NZ230868A (en) Dihydroartemisinin derivatives, preparation and pharmaceutical compositions thereof
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
HK118494A (en) Pharmaceutical use of graminaceous extracts
IL88989A0 (en) 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them
IL87089A (en) Derivatives of n-aminobutyl-n- phenylarylamides, their preparation and pharmaceutical compositions containing them
GB2215208B (en) Transdermal administration of plant extracts
IL96384A0 (en) Pyridazine derivatives,their preparation and pharmaceutical compositions containing them
EP0409893A4 (en) Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
HU900608D0 (en) Process for preparation of lactame-derivatives and pharmaceutical preparations containing them
IL91356A0 (en) Therapeutic nucleosides,their preparation and pharmaceutical compositions containing them
PH24960A (en) Acyl derivatives and pharmaceutical preparation thereof
NZ229023A (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910122

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 19910515

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 19920622

19U Interruption of proceedings before grant

Effective date: 19940326

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20210201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210501